Automatic classification of MR scans in Alzheimer's disease.

To be diagnostically useful, structural MRI must reliably distinguish Alzheimer's disease (AD) from normal aging in individual scans. Recent advances in statistical learning theory have led to the application of support vector machines to MRI for detection of a variety of disease states. The aims of this study were to assess how successfully support vector machines assigned individual diagnoses and to determine whether data-sets combined from multiple scanners and different centres could be used to obtain effective classification of scans. We used linear support vector machines to classify the grey matter segment of T1-weighted MR scans from pathologically proven AD patients and cognitively normal elderly individuals obtained from two centres with different scanning equipment. Because the clinical diagnosis of mild AD is difficult we also tested the ability of support vector machines to differentiate control scans from patients without post-mortem confirmation. Finally we sought to use these methods to differentiate scans between patients suffering from AD from those with frontotemporal lobar degeneration. Up to 96% of pathologically verified AD patients were correctly classified using whole brain images. Data from different centres were successfully combined achieving comparable results from the separate analyses. Importantly, data from one centre could be used to train a support vector machine to accurately differentiate AD and normal ageing scans obtained from another centre with different subjects and different scanner equipment. Patients with mild, clinically probable AD and age/sex matched controls were correctly separated in 89% of cases which is compatible with published diagnosis rates in the best clinical centres. This method correctly assigned 89% of patients with post-mortem confirmed diagnosis of either AD or frontotemporal lobar degeneration to their respective group. Our study leads to three conclusions: Firstly, support vector machines successfully separate patients with AD from healthy aging subjects. Secondly, they perform well in the differential diagnosis of two different forms of dementia. Thirdly, the method is robust and can be generalized across different centres. This suggests an important role for computer based diagnostic image analysis for clinical practice.

[1]  J. Winn,et al.  Brain , 1878, The Lancet.

[2]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[3]  C. Reynolds,et al.  Wechsler memory scale-revised , 1988 .

[4]  J. Morris,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease , 1989, Neurology.

[5]  Robert A. Bornstein,et al.  The Wechsler Memory Scale—Revised , 1990 .

[6]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[7]  C. Jack,et al.  MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease , 1992, Neurology.

[8]  J. Rabe-Jabłońska,et al.  [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders]. , 1993, Psychiatria polska.

[9]  C. Cotman,et al.  Neural-network-based classification of cognitively normal, demented, Alzheimer disease and vascular dementia from single photon emission with computed tomography image data from brain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[10]  John Q. Trojanowski,et al.  Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease , 1997, Neurobiology of Aging.

[11]  J. Trojanowski,et al.  Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[12]  Vladimir Vapnik,et al.  Statistical learning theory , 1998 .

[13]  R. Faber,et al.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.

[14]  V. Valcour,et al.  The detection of dementia in the primary care setting. , 2000, Archives of internal medicine.

[15]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[16]  B Miller,et al.  Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. , 2001, Archives of neurology.

[17]  M N Rossor,et al.  Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease , 2001, Annals of neurology.

[18]  B. Miller,et al.  CME Practice parameter : Diagnosis of dementia ( an evidence-based review ) Report of the Quality Standards Subcommittee of the American Academy of Neurology , 2001 .

[19]  Jeffrey L. Cummings,et al.  Practice parameter: Diagnosis of dementia (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology , 2001 .

[20]  W. Markesbery,et al.  Hippocampal volume as an index of Alzheimer neuropathology: Findings from the Nun Study , 2002, Neurology.

[21]  L. Thal,et al.  Alzheimer’s disease can be accurately diagnosed in very mildly impaired individuals , 2002, Neurology.

[22]  et al.,et al.  Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET , 2002, NeuroImage.

[23]  C. Jack,et al.  Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia , 2002, Neurology.

[24]  M. Oremus,et al.  Donepezil and rivastigmine in the treatment of Alzheimer's disease: a best-evidence synthesis of the published data on their efficacy and cost-effectiveness. , 2002, Clinical therapeutics.

[25]  Dinggang Shen,et al.  Morphological classification of brains via high-dimensional shape transformations and machine learning methods , 2004, NeuroImage.

[26]  Nick C. Fox,et al.  Differentiating AD from aging using semiautomated measurement of hippocampal atrophy rates , 2004, NeuroImage.

[27]  Lei Wang,et al.  Correlations Between Antemortem Hippocampal Volume and Postmortem Neuropathology in AD Subjects , 2004, Alzheimer disease and associated disorders.

[28]  Nick C Fox,et al.  Imaging cerebral atrophy: normal ageing to Alzheimer's disease , 2004, The Lancet.

[29]  C. Jack,et al.  Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD , 2004, Neurology.

[30]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[31]  Gunhild Waldemar,et al.  Evidence-based Evaluation of Magnetic Resonance Imaging as a Diagnostic Tool in Dementia Workup , 2005, Topics in magnetic resonance imaging : TMRI.

[32]  Dinggang Shen,et al.  Classification of Structural Images via High-Dimensional Image Warping, Robust Feature Extraction, and SVM , 2005, MICCAI.

[33]  Takashi Asada,et al.  Voxel-based morphometry to discriminate early Alzheimer's disease from controls , 2005, Neuroscience Letters.

[34]  P. Solomon,et al.  Should we screen for Alzheimer's disease? A review of the evidence for and against screening Alzheimer's disease in primary care practice. , 2005, Geriatrics.

[35]  C. Jack,et al.  Alzheimer's Disease Neuroimaging Initiative , 2008 .

[36]  Janaina Mourão Miranda,et al.  Classifying brain states and determining the discriminating activation patterns: Support Vector Machine on functional MRI data , 2005, NeuroImage.

[37]  Chronic pain management in older adults: with coxibs under fire, what now? , 2005, Geriatrics.

[38]  Timo Grimmer,et al.  Mapping scores onto stages: mini-mental state examination and clinical dementia rating. , 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[39]  Nick C Fox,et al.  Apolipoprotein e genotype modifies the phenotype of Alzheimer disease. , 2006, Archives of neurology.

[40]  C. Mathers,et al.  Global prevalence of dementia: a Delphi consensus study , 2005, The Lancet.

[41]  Karalyn Patterson,et al.  Clinical and pathological characterization of progressive aphasia , 2006, Annals of neurology.

[42]  J. Schneider,et al.  Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration , 2007, Acta Neuropathologica.

[43]  N. Schuff,et al.  Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. , 2006, Brain : a journal of neurology.

[44]  John Ashburner,et al.  A fast diffeomorphic image registration algorithm , 2007, NeuroImage.

[45]  Radford M. Neal Pattern Recognition and Machine Learning , 2007, Technometrics.

[46]  Kiralee M. Hayashi,et al.  The topography of grey matter involvement in early and late onset Alzheimer's disease. , 2007, Brain : a journal of neurology.

[47]  Maximilian Reiser,et al.  Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment , 2007, NeuroImage.

[48]  Bruce L. Miller,et al.  Appendix B: Practice parameter: Diagnosis of dementia (an evidence-based review): Report of the quality standards subcommittee of the American academy neurology , 2007 .

[49]  Ferath Kherif,et al.  Multivariate voxel-based morphometry successfully differentiates schizophrenia patients from healthy controls , 2007, NeuroImage.

[50]  Clifford R. Jack,et al.  Interpreting scan data acquired from multiple scanners: A study with Alzheimer's disease , 2008, NeuroImage.

[51]  S. Resnick,et al.  Detection of prodromal Alzheimer's disease via pattern classification of magnetic resonance imaging , 2008, Neurobiology of Aging.

[52]  Alan C. Evans,et al.  Automated cortical thickness measurements from MRI can accurately separate Alzheimer's patients from normal elderly controls , 2008, Neurobiology of Aging.

[53]  Ronald C Petersen,et al.  Detection of prodromal Alzheimer's disease , 2008, Annals of neurology.